Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy

被引:0
|
作者
Gyda Lolk Ottesen
Ib Jarle Christensen
Jørgen K. Larsen
Jacob Larsen
Bo Baldetorp
Thomas Linden
Bodil Hansen
Johan Andersen
机构
[1] University of Copenhagen,Department of Forensic Pathology
[2] Rigshospitalet,Finsen Laboratory, Finsen Center
[3] Lund University Hospital,Department of Oncology
[4] Odense University Hospital,Institute of Pathology
来源
关键词
breast; carcinoma ; DNA ploidy; histopathology; immunohistochemistry; invasive carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
In a consecutive and unselected series of 178 cases of carcinoma in situ of the breast (CIS), comprising both ductal (DCIS) and lobular type (LCIS), and a series of 48 cases of invasive carcinoma (IC) with predominance of DCIS, the association between histopathology, immunohistochemical markers (ER, PgR, MIB-1, c-erbB-2, and p53), and DNA ploidy was investigated, in order to discriminate biologically different groups. In DCIS, significant correlation was shown between large nuclear size and comedonecrosis, both of which showed also strong association to DNA aneuploidy, high proliferation activity, low steroid receptor content, and overexpression of c-erbB-2 and p53 – factors that may indicate an aggressive behavior. Small nuclear CIS, whether LCIS or DCIS, on the contrary, were DNA diploid with low proliferation, and no cases showed overexpression of c-erbB-2 and p53. Heterogeneity with respect to the investigated parameters was also a frequent finding that may reflect a development complexity. In IC, comparison of the DCIS and the invasive component showed similar patterns. No significant differences were shown between DCIS without and with invasion. This may indicate that none of the investigated parameters on its own are essential for the event of invasion.
引用
收藏
页码:219 / 226
页数:7
相关论文
共 50 条
  • [31] Impact of Tissue Decalcification on Immunohistochemical Detection of Breast Carcinoma Markers
    Shi, Jianhui
    Xu, Vivian
    Liu, Haiyan
    Lin, Fan
    MODERN PATHOLOGY, 2015, 28 : 66A - 66A
  • [32] The Role of Novel Immunohistochemical Markers for Special Types of Breast Carcinoma
    Grabenstetter, Anne
    D'Alfonso, Timothy M.
    ADVANCES IN ANATOMIC PATHOLOGY, 2023, 30 (06) : 374 - 379
  • [33] IMMUNOHISTOCHEMICAL DEMONSTRATION OF BIOLOGIC MARKERS IN MALE BREAST-CARCINOMA
    DANIELSON, C
    BLOCK, T
    BRODHECKER, C
    PENNINGTON, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 89 (03) : 434 - 434
  • [34] Impact of Tissue Decalcification on Immunohistochemical Detection of Breast Carcinoma Markers
    Shi, Jianhui
    Xu, Vivian
    Liu, Haiyan
    Lin, Fan
    LABORATORY INVESTIGATION, 2015, 95 : 66A - 66A
  • [35] DNA ploidy in relationship with EZH2 expression as markers of breast carcinomas
    Panoussis, D.
    Ntasiou, P.
    Kyriakidou, V.
    Patsouris, E.
    Koufoudakis, D.
    Xepapadakis, G.
    Koronarchis, D.
    Athanassiadou, A. M.
    Athanassiadou, P.
    EJC SUPPLEMENTS, 2010, 8 (03): : 114 - 114
  • [36] HISTOPATHOLOGY, DNA-PLOIDY AND KARYOTYPE IN EPITHELIOID SARCOMA
    MOLENAAR, WM
    IDENBURG, VJS
    TAMMINGA, R
    BUIST, J
    DAMMEIRING, A
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 349 - 349
  • [37] Microcalcifications in ductal carcinoma in situ of the breast: Histochemical and immunohistochemical study
    Foschini, MP
    Fornelli, A
    Peterse, JL
    Mignani, S
    Eusebi, V
    HUMAN PATHOLOGY, 1996, 27 (02) : 178 - 183
  • [38] Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast
    Karayiannakis, AJ
    Bastounis, EA
    Chatzigianni, EB
    Makri, GG
    Alexiou, D
    Karamanakos, P
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (06): : 578 - 582
  • [39] DNA Ploidy is an Independent Prognostic Biomarker in Breast Invasive Ductal Carcinoma
    Pinto, Antonio E.
    Pereira, Teresa
    Silva, Giovani L.
    Ferreira, Monica C.
    Andre, Saudade
    ACTA MEDICA PORTUGUESA, 2012, 25 (06): : 399 - 407
  • [40] CORRELATION BETWEEN PLOIDY STATUS, ERB-B2 AND P53 IMMUNOHISTOCHEMICAL EXPRESSION IN PRIMARY BREAST-CARCINOMA
    MIDULLA, C
    GIOVAGNOLI, MR
    VALLI, C
    VECCHIONE, A
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1995, 17 (03): : 157 - 162